Research programme: small molecule therapeutics - BYOMass
Latest Information Update: 03 Nov 2021
At a glance
- Originator BYOMass
- Class Small molecules
- Mechanism of Action Transforming growth factor beta modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 19 Oct 2021 Early research in Unspecified in USA (unspecified route) prior to October 2021 (BYOMass website, October 2021)